ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 728317 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 728317; 2) Community: the network communities that were significantly associated with the response to NSC 728317; 3) Molecule: the relationships between components within communities and NSC 728317; 4) MDR: the compounds that were significantly associated with the NSC 728317.

NSC Compound Enrichment Correlation
NSC 651593 Null 0.0178844438004194 0.13838757
NSC 658103 Null 0.0178844438004194 0.44539657
NSC 672215 Null 0.0178844438004194 0.32378574
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0178844438004194 0.26172865
NSC 681636 Camptothecin Derivative 0.0178844438004194 0.45061804
NSC 681645 Camptothecin Derivative 0.0178844438004194 0.45201413
NSC 687305 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone 0.0178844438004194 0.36666125
NSC 695590 Null 0.0178844438004194 0.37730407
NSC 696075 Null 0.0178844438004194 0.16258502
NSC 696257 2,3-Dihydro-1,2-syn-2-[S-(L)-cysteinylsulfoxide-]-brefeldin A 0.0178844438004194 -0.10285505
Total:116  Current:50    [First] [Prev] [Next] [Last]